Interview with Sean Whooley - National Diabetes Month
In this video, Sean Whooley, Associate Editor at MassDevice, & head driver of Drug Delivery News, sits down with Kayleen Brown, Managing Editor at DeviceTalks, to talk all things diabetes, in honor of #NationalDiabetesMonth.
During the interview, Sean discusses:
- Lessons learned from covering news for DDBN
- How Sean got into covering the #DiabetesIndustry
- His thoughts on interviewing key leaders in the diabetes space
- What he enjoys most about covering the #Diabetes industry
- The #MedicalDevices/#DrugDevices that are needed for those in the #DiabetesCommunity
- Some big stories he covered in 2024, such as; news from Medtronic, Abbott, Dexcom, Tandem Diabetes Care, Beta Bionics, & #Insulet
- His reflection on attending the American Diabetes Association Scientific Sessions in June
- And much more!
Kayleen also shares a personal story on her connection to the Diabetes Community.
Watch the video below, & for the for the biggest #DiabetesTech stories of the year so far, & what diabetes tech companies have been up to this month, see the comment section below 🔽 🔽
#PatientCare #Healthcare #DiabetesAwareness #DiabetesCare #InsulinDelivery #InsulinPumps #CGM #BloodGlucose #Insulin #DiabetesWellBeing #DiabetesMonth #DiabetesLife International Diabetes Federation
It's World Diabetes Day! In honor of this, our Associate Editor and head driver of Drug Delivery News, Sean Whooley, has a message for the #DiabetesCommunity!
If you have any Diabetes stories you would like to share, please reach out to Sean on LinkedIn!
Also, if you're looking for the biggest #DiabetesTech stories of the year so far, or are interested in learning more about what #Diabetes tech companies are doing on #WorldDiabetesDay, please see the links in the comment below 🔽 🔽
#CGM #BloodGlucose #Insulin #DiabetesWellBeing #DiabetesMonth #DiabetesLife #DiabetesCare International Diabetes Federation
The words "Pioneer" & "Maverick" are used far too often & far too inaccurately.
But in this case, there are no better words to describe one of the most influential founders of the neurovascular field, Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director, Pediatric Cerebrovascular Surgery, Mount Sinai Health System.
J&J MedTech's John Murray brings to the forefront a brief look into Dr. Berenstein's illustrious career in Episode 1 of #NeuroInnovationTalks.
Thank you to Zeus for sponsoring this episode!
Link to the full #VideoPodcast in comments. 🔽 🔽
And yes, before you ask, that is Dr. Berenstein with the Dalai Lama.
#neurovascular #medtech #MedicalDevices #stroke #BloodClots #neuro #neurology #StrokeCare #NeurovascularSurgery #Neurosurgery
Episode 1 of the brand new series Neuro Innovation Talks has just launched!!
For this new video podcast series, we've invited Johnson & Johnson MedTech Neurovascular’s Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the #StrokeIndustry!
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks!
#neuro #neurovacular #vascular #NeurovascularSurgery #NeuroTalks #stroke Johnson & Johnson
Introducing....Structural Heart Talks Podcast
In our inaugural episode of the #StructuralHeartTalks podcast, Daveen Chopra, Corporate VP and GM of TMTT, unpacks the challenges and innovations in treating #mitral and #tricuspid valve diseases.
Discover how Edwards Lifesciences is pioneering with technologies like PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first #transcatheter #TricuspidValve replacement approved in both the US and Europe.
Thank you to Edwards Lifesciences for hosting DeviceTalks onsite and to our episode sponsor, Resonetics for helping make this episode possible!
#HeartValveDisease #MedTech #EdwardsLifesciences #HeartValve #podcast
Ortho Innovation Talks Podcast | Will future “Portfolio Transformation" come from M&A or R&D?
Will future “Portfolio Transformation" come from M&A or R&D?
In the inaugural episode of #OrthoInnovationTalks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses.
Thank you to our sponsors AcuityMD Millstone Medical for providing vital support.
Listen to the clip below 🔽, and for the full episode, VISIT: https://www.devicetalks.com/zimmer-biomet-growth-strategy-innovation-acquisitions/?utm_source=SocialMedia&utm_medium=Facebook&utm_campaign=OIT010324
#ortho #orthopedics #OEM #CompanyGrowth #innovation #MergersAndAcquisitions